NIAID Banner Logo Image

ONLINE DATABASE SEARCH - HIV-LS-302-MEMO

1. 43847 HIV-LS-302; PUBMED-HIV-8/10/2004

Inhibitory Effects of Some Traditional Medicines on Proliferation of HIV-1 and Its Protease

Nakamura, N

Yakugaku Zasshi 2004. 124(8): 519-29

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15297721&dopt=abstract


2. 43848 HIV-LS-302; PUBMED-HIV-8/10/2004

Metabolites produced by actinomycetes -antiviral antibiotics and enzyme inhibitors-

Uyeda, M

Yakugaku Zasshi 2004. 124(8): 469-79

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15297717&dopt=abstract


3. 43849 HIV-LS-302; EMBASE-HIV-8/10/2004

Primer unblocking by HIV-1 reverse transcriptase and resistance to nucleoside RT inhibitors (NRTIs)

Goldschmidt, Valerie and Marquet, Roland

The International Journal of Biochemistry & Cell Biology 2004. 36(9): 1687-1705

HYPERLINK:  http://www.sciencedirect.com/science/article/B6TCH-4CBVS67-5/2/9c6a6ada8af67fe7c343416e7211f9f4


4. 43850 HIV-LS-302; PUBMED-HIV-8/10/2004

Screening assay for the identification of deoxyhypusine synthase inhibitors

Sommer, MN, Bevec, D, Klebl, B, Flicke, B, Holscher, K, Freudenreich, T, Hauber, I, Hauber, J, and Mett, H

J Biomol Screen 2004. 9(5): 434-8

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15296643&dopt=abstract


5. 43851 HIV-LS-302; EMBASE-HIV-8/10/2004

Nucleoside-analog resistance mutations in HIV-1 reverse transcriptase and their influence on polymerase fidelity and viral mutation rates

Rezende, Lisa F and Prasad, Vinayaka R

The International Journal of Biochemistry & Cell Biology 2004. 36(9): 1716-1734

HYPERLINK:  http://www.sciencedirect.com/science/article/B6TCH-4CCNSCT-1/2/938ce7ca91fb2f824fbcae862b6182ac


6. 43852 HIV-LS-302; PUBMED-HIV-8/10/2004

Inhibitor design by wrapping packing defects in HIV-1 proteins

Fernandez, A, Rogale, K, Scott, R, and Scheraga, HA

Proc Natl Acad Sci U S A 2004

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15289598&dopt=abstract


7. 43853 HIV-LS-302; EMBASE-HIV-8/10/2004

Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo

Notka, Frank, Meier, Georg, and Wagner, Ralf

Antiviral Research 2004. In Press, Uncorrected Proof

HYPERLINK:  http://www.sciencedirect.com/science/article/B6T2H-4D1MTW2-1/2/056d693b4ebe293c9df208555d351151


8. 43854 HIV-LS-302; PUBMED-HIV-8/10/2004

Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance

Ross, L, Parkin, N, Chappey, C, Fisher, R, Clair, MS, Bates, M, Tisdale, M, and Lanier, ER

AIDS 2004. 18(12): 1691-6

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15280780&dopt=abstract


9. 43855 HIV-LS-302; PUBMED-HIV-8/10/2004

Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency

Nikolenko, GN, Svarovskaia, ES, Delviks, KA, and Pathak, VK

J Virol 2004. 78(16): 8761-70

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15280484&dopt=abstract


10. 43856 HIV-LS-302; PUBMED-HIV-8/10/2004

Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro

Maeda, K, Nakata, H, Koh, Y, Miyakawa, T, Ogata, H, Takaoka, Y, Shibayama, S, Sagawa, K, Fukushima, D, Moravek, J, Koyanagi, Y, and Mitsuya, H

J Virol 2004. 78(16): 8654-62

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15280474&dopt=abstract


11. 43857 HIV-LS-302; PUBMED-HIV-8/10/2004

Initial Cleavage of the Human Immunodeficiency Virus Type 1 GagPol Precursor by Its Activated Protease Occurs by an Intramolecular Mechanism

Pettit, SC, Everitt, LE, Choudhury, S, Dunn, BM, and Kaplan, AH

J Virol 2004. 78(16): 8477-85

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15280456&dopt=abstract


12. 43858 HIV-LS-302; PUBMED-HIV-8/10/2004

The challenge of antiretroviral-drug-resistant HIV: is there any possible clinical advantage?

Zaccarelli, M, Tozzi, V, Perno, CF, and Antinori, A

Curr HIV Res 2004. 2(3): 283-92

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15279592&dopt=abstract


13. 43859 HIV-LS-302; PUBMED-HIV-8/10/2004

From the Cover: A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase

Hazuda, DJ, Anthony, NJ, Gomez, RP, Jolly, SM, Wai, JS, Zhuang, L, Fisher, TE, Embrey, M, Guare, JP Jr, Egbertson, MS, Vacca, JP, Huff, JR, Felock, PJ, Witmer, MV, Stillmock, KA, Danovich, R, Grobler, J, Miller, MD, Espeseth, AS, Jin, L, Chen, IW, Lin, JH, Kassahun, K, Ellis, JD, Wong, BK, Xu, W, Pearson, PG, Schleif, WA, Cortese, R, Emini, E, Summa, V, Holloway, MK, and Young, SD

Proc Natl Acad Sci U S A 2004. 101(31): 11233-8

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15277684&dopt=abstract


14. 43860 HIV-LS-302; EMBASE-HIV-8/10/2004

A polymeric immunoglobulin receptor-like milk protein with inhibitory activity on human immunodeficiency virus type 1 reverse transcriptase

Ng, TB and Ye, XY

The International Journal of Biochemistry & Cell Biology 2004. In Press, Corrected Proof

HYPERLINK:  http://www.sciencedirect.com/science/article/B6TCH-4CVX2KS-1/2/958ddeb20d03be20e2a5378cbb8b08db


15. 43861 HIV-LS-302; PUBMED-HIV-8/10/2004

Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes

Miao, B, Geng, M, Li, J, Li, F, Chen, H, Guan, H, and Ding, J

Biochem Pharmacol 2004. 68(4): 641-9

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15276071&dopt=abstract


16. 43862 HIV-LS-302; PUBMED-HIV-8/10/2004

Zidovudine, lamivudine, and abacavir have different effects on resting cells infected with human immunodeficiency virus in vitro

Saavedra-Lozano, J, McCoig, CC, Cao, Y, Vitetta, ES, and Ramilo, O

Antimicrob Agents Chemother 2004. 48(8): 2825-30

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15273087&dopt=abstract


17. 43863 HIV-LS-302; PUBMED-HIV-8/10/2004

Efficient 3D Database Screening for Novel HIV-1 IN Inhibitors

Barreca, ML, Rao, A, De Luca, L, Zappala, M, Gurnari, C, Monforte, P, De Clercq, E, Van Maele, B, Debyser, Z, Witvrouw, M, Briggs, JM, and Chimirri, A

J Chem Inf Comput Sci 2004. 44(4): 1450-1455

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15272853&dopt=abstract


18. 43864 HIV-LS-302; PUBMED-HIV-8/10/2004

Systemic and mucosal immunity in rhesus macaques immunized with HIV-1 peptide and gp120 conjugated to Brucella abortus

Eller, N, Golding, H, Inoue, S, Beining, P, Inman, J, Matthews, N, Scott, DE, and Golding, B

J Med Primatol 2004. 33(4): 167-174

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15271066&dopt=abstract


19. 43865 HIV-LS-302; EMBASE-HIV-8/10/2004

Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes

Holguin, Africa, Paxinos, Ellen, Hertogs, Kurt, Womac, Chad, and Soriano, Vincent

Journal of Clinical Virology 2004. In Press, Corrected Proof

HYPERLINK:  http://www.sciencedirect.com/science/article/B6VJV-4CF3C93-1/2/98086dc01c8d6eaf303cd4fcc7c51bc1


20. 43866 HIV-LS-302; PUBMED-HIV-8/10/2004

New Antiretroviral Agents for the Treatment of HIV Infection

Marks, K and Gulick, RM

Curr Infect Dis Rep 2004. 6(4): 333-339

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15265463&dopt=abstract


21. 43867 HIV-LS-302; PUBMED-HIV-8/10/2004

Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients

Torti, C, Quiros-Roldan, E, Monno, L, Patroni, A, Saracino, A, Angarano, G, Tinelli, C, Lo, Caputo S, Tirelli, V, Mazzotta, F, and Carosi, G

J Med Virol 2004. 74(1): 29-33

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15258965&dopt=abstract


22. 43868 HIV-LS-302; PUBMED-HIV-8/10/2004

Antiretroviral and immunosuppressive drug-drug interactions: An update

Izzedine, H, Launay-Vacher, V, Baumelou, A, and Deray, G

Kidney Int 2004. 66(2): 532-541

HYPERLINK:  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15253704&dopt=abstract


23. 43869 HIV-LS-302; WOS-HIV-8/2/2004

Tryptophan scanning mutagenesis of aromatic residues within the polymerase domain of HIV-l reverse transcriptase: critical role of Phe-130 for p51 function and second-site revertant restoring viral replication capacity

Olivares, I, Gutierrez-Rivas, M, Lopez-Galindez, C, and Menendez-Arias, L

VIROLOGY 2004. 324(2): 400-411

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222376800014


24. 43870 HIV-LS-302; WOS-HIV-8/2/2004

Preparation and pharmacokinetics of C-11 labeled stavudine (d4T)

Livni, E, Berker, M, Hillier, S, Waller, SC, Ogan, MD, Discordia, RP, Rienhart, JK, Rubin, RH, and Fischman, AJ

NUCL MED BIOL 2004. 31(5): 613-621

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222425900011


25. 43871 HIV-LS-302; WOS-HIV-8/2/2004

Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion

Rawat, SS, Gallo, SA, Eaton, J, Martin, TD, Ablan, S, KewalRamani, VN, Wang, JM, Blumenthal, R, and Puri, A

J VIROL 2004. 78(14): 7360-7368

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222407200008


26. 43872 HIV-LS-302; WOS-HIV-8/2/2004

Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction site

Heil, ML, Decker, JM, Sfakianos, JN, Shaw, GM, Hunter, E, and Derdeyn, CA

J VIROL 2004. 78(14): 7582-7589

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222407200032


27. 43873 HIV-LS-302; WOS-HIV-8/2/2004

Recent advances in the development of next generation non-nucleoside reverse transcriptase inhibitors

Tarby, CM

CURR TOP MED CHEM 2004. 4(10): 1045-1057

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222455200004


28. 43874 HIV-LS-302; WOS-HIV-8/2/2004

Ampelopsin, a small molecule inhibitor of HIV-1 infection targeting HIV entry

Liu, DY, Ye, JT, Yang, WH, Yan, J, Zeng, CH, and Zeng, S

BIOMED ENVIRON SCI 2004. 17(2): 153-164

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222414600004


29. 43875 HIV-LS-302; WOS-HIV-8/2/2004

gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction

Wu, ZW, Golub, E, Abrams, WR, and Malamud, D

AIDS RES HUM RETROV 2004. 20(6): 600-607

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222347000005


30. 43876 HIV-LS-302; WOS-HIV-8/8/2004

Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1

Sayah, DM, Sokolskaja, E, Berthoux, L, and Luban, J

NATURE 2004. 430(6999): 569-573

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222946100050


31. 43877 HIV-LS-302; WOS-HIV-8/8/2004

Camelized rabbit-derived VH single-domain Intrabodies Against vif strongly neutralize HIV-1 infectivity

da Silva, FA, Santa-Marta, M, Freitas-Vieira, A, Mascarenhas, P, Barahona, I, Moniz-Pereira, J, Gabuzda, D, and Goncalves, J

J MOL BIOL 2004. 340(3): 525-542

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222560000011


32. 43878 HIV-LS-302; WOS-HIV-8/8/2004

Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirs

Pires, A, Hardy, G, Gazzard, B, Gotch, F, and Imami, N

JAIDS-J ACQ IMM DEF 2004. 36(3): 783-790

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222481700003


33. 43879 HIV-LS-302; WOS-HIV-8/8/2004

Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity

Romanelli, F, Smith, KM, and Hoven, AD

CURR PHARM DESIGN 2004. 10(21): 2643-2648

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222539600009


34. 43880 HIV-LS-302; WOS-HIV-8/8/2004

Increased expression of Toll-like receptor 2 on monocytes in HIV infection: Possible roles in inflammation and viral replication

Heggelund, L, Muller, F, Lien, E, Yndestad, A, Ueland, T, Kristiansen, KI, Espevik, T, Aukrust, P, and Froland, SS

CLIN INFECT DIS 2004. 39(2): 264-269

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222474300018


35. 43881 HIV-LS-302; WOS-HIV-8/8/2004

Intracellular expression of antisense RNA. transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells

Barnor, JS, Miyano-Kurosaki, N, Yamaguchi, K, Sakamoto, A, Ishikawa, K, Inagaki, Y, Yamamoto, N, Osei-Kwasi, M, Ofori-Adjei, D, and Takaku, H

BIOCHEM BIOPH RES CO 2004. 320(2): 544-550

HYPERLINK:  http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222567700040


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2024